Serum YKL-40 level was higher in the CHD patients compared with that in HCs [median (IQR): 100.2 (79.6–148.6) ng/ml vs. 51.7 (31.5–65.9) ng/ml, P < 0.001] (Figure 1A). This evidence concerns the gene CHI3L1 and coronary artery disorder.